Hexagon Capital Partners LLC - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 43 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Hexagon Capital Partners LLC ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2021$5,000
-16.7%
5,0000.0%0.00%
-50.0%
Q2 2021$6,000
+50.0%
5,0000.0%0.00%
+100.0%
Q1 2021$4,000
+33.3%
5,000
-28.6%
0.00%0.0%
Q4 2020$3,000
-25.0%
7,0000.0%0.00%0.0%
Q3 2020$4,0007,0000.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Greenlight Capital 292,366$283,0000.02%
Virtu Financial LLC 204,870$199,0000.02%
Verdence Capital Advisors LLC 143,382$139,0000.02%
Founders Capital Management 18,000$17,0000.01%
WOLFF WIESE MAGANA LLC 10,740$10,0000.01%
Global Strategic Investment Solutions, LLC 23,000$22,0000.00%
Belvedere Trading LLC 118,500$146,0000.00%
Affinity Capital Advisors, LLC 13,180$13,0000.00%
Atom Investors LP 56,492$55,0000.00%
Stonebridge Capital Advisors LLC 22,000$21,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders